# Bubiket Study: Ultrasound Guided Fascia Iliaca Nerve Block With Bupivacaine and Adjuvant Ketamine vs. Bupivacaine Alone

> **NCT03909594** · PHASE4 · WITHDRAWN · sponsor: **Antonios Likourezos**

## Conditions studied

- Pain, Musculoskeletal

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT03909594
- **Lead sponsor:** Antonios Likourezos
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The COVID Pandemic delayed start of study and currently the investigators are not interested in conducting the study.
- **Last updated:** 2021-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909594, "Bubiket Study: Ultrasound Guided Fascia Iliaca Nerve Block With Bupivacaine and Adjuvant Ketamine vs. Bupivacaine Alone". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03909594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*